CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 95 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,193,360 | -12.8% | 3,629,000 | 0.0% | 0.89% | -11.0% |
| Q3 2022 | $24,314,000 | +59.1% | 3,629,000 | 0.0% | 1.00% | +36.0% |
| Q2 2022 | $15,278,000 | +101.2% | 3,629,000 | +61.1% | 0.74% | +142.8% |
| Q1 2022 | $7,593,000 | +7.0% | 2,253,000 | 0.0% | 0.30% | +17.8% |
| Q4 2021 | $7,097,000 | -63.7% | 2,253,000 | +38.4% | 0.26% | -87.9% |
| Q2 2019 | $19,538,000 | +16.8% | 1,628,187 | +17.5% | 2.13% | +13.9% |
| Q1 2019 | $16,723,000 | +15.8% | 1,385,487 | +20.4% | 1.87% | -0.7% |
| Q4 2018 | $14,438,000 | -38.9% | 1,150,445 | -27.7% | 1.89% | -9.1% |
| Q3 2018 | $23,627,000 | -22.7% | 1,592,138 | -12.4% | 2.08% | -30.5% |
| Q2 2018 | $30,582,000 | -30.9% | 1,817,138 | -6.0% | 2.98% | -33.4% |
| Q1 2018 | $44,246,000 | -13.2% | 1,932,123 | -1.9% | 4.48% | -27.0% |
| Q4 2017 | $50,958,000 | +10.2% | 1,969,789 | -37.2% | 6.14% | +4.5% |
| Q3 2017 | $46,246,000 | +78.5% | 3,135,289 | +68.8% | 5.88% | +46.1% |
| Q2 2017 | $25,904,000 | -35.0% | 1,856,895 | -20.5% | 4.02% | -40.7% |
| Q1 2017 | $39,863,000 | +48.1% | 2,336,609 | -10.7% | 6.78% | +25.3% |
| Q4 2016 | $26,921,000 | -2.2% | 2,616,249 | -3.9% | 5.41% | +4.3% |
| Q3 2016 | $27,532,000 | -11.0% | 2,723,210 | -1.2% | 5.19% | -21.3% |
| Q2 2016 | $30,942,000 | -17.8% | 2,755,318 | 0.0% | 6.59% | -29.2% |
| Q1 2016 | $37,638,000 | -11.1% | 2,755,318 | +23.4% | 9.31% | +29.1% |
| Q4 2015 | $42,341,000 | +0.0% | 2,232,014 | -1.0% | 7.22% | -15.6% |
| Q3 2015 | $42,330,000 | +12.7% | 2,255,168 | -10.6% | 8.55% | +29.0% |
| Q2 2015 | $37,544,000 | +84.9% | 2,521,452 | +88.1% | 6.63% | +56.1% |
| Q1 2015 | $20,304,000 | +26.3% | 1,340,659 | +11.1% | 4.25% | +35.8% |
| Q4 2014 | $16,070,000 | +5.6% | 1,206,459 | 0.0% | 3.13% | -1.0% |
| Q3 2014 | $15,213,000 | – | 1,206,459 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |